3. Vascular Solutions ( VASC) is a medical device company that focuses on providing clinically advanced solutions for interventional cardiologists and radiologists, worldwide.
For 2010 fourth quarter, analysts polled by Bloomberg expect the company to report earnings of 96 cents per share, compared to earnings of 10 cents per share and 9 cents per share during the year-ago and quarter-ago periods, respectively. Analysts estimate the company to report earnings per share of $1.35 cents for 2010, a significant improvement from earnings of 33 cents per share reported for 2009. Over the past one year, the stock surged around 38%. In comparison Baxter International ( BAX), Covidien ( COV), C.R. Bard ( BCR), and Teleflex ( TFX) returned around -14%, -6%, 16%, and -2%, respectively. All the seven analysts covering the stock recommend buying. Analysts expect the stock to gain around 34% over the next 12 months with a consensus target price of $14.9.